TI
ALXN

Telemetry Investments’s Alexion Pharmaceuticals ALXN Stock Holding History

Telemetry Investments’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,000
Closed -$2.39M – 198
2021
Q2 		$2.39M Buy
13,000
+4,900
+60% +$841K 3.28% 3
2021
Q1 		$1.24M Buy
+8,100
New +$1.25M 1.4% 19
2020
Q3 		– Sell
-2,000
Closed -$224K – 75
2020
Q2 		$224K Buy
+2,000
New +$212K 0.61% 52

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Telemetry Investments's ALXN Position: Q3 2021 in Review

Telemetry Investments sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 13,000 shares — an estimated $2.39M sold.

Telemetry Investments first reported a position in ALXN in Q2 2020 and held it in 3 quarters. The position peaked at $2.39M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Telemetry Investments reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Telemetry Investments sold 13,000 Alexion Pharmaceuticals shares in Q3 2021, an estimated $2.39M.
  • Telemetry Investments first reported a position in Alexion Pharmaceuticals in Q2 2020 and held it in 3 quarters.
  • Telemetry Investments's Alexion Pharmaceuticals position peaked at $2.39M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Telemetry Investments's 13F filing for Q3 2021, filed 15 Nov 2021.